{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-072251","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2024-08-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.257043+00:00","generated_at":"2026-05-31T07:56:37.788293+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"ARCA shareholders approve merger with Oruka; 1-for-12 reverse split set for Sept 3 trading under ORKA","bullets":["Shareholders approved all 9 proposals at Aug 22 special meeting, including merger, share increase to 545M, and reverse split.","Board set reverse stock split ratio at 1-for-12; outstanding shares to drop from ~14.5M to ~1.21M.","Post-merger combined company expected to have ~29.5M common shares, plus ~5.4M pre-funded warrants and ~11.4M Series B convertible shares.","Merger expected to close Aug 29; shares to trade as Oruka Therapeutics under ticker 'ORKA' on Nasdaq Global Market starting Sept 3.","New CUSIP 687604108 and ISIN US6876041087 assigned after reverse split; cash in lieu of fractional shares at Sept 3 closing price."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-072251","json":"https://secwatch.observer/filing/0001213900-24-072251.json","markdown":"https://secwatch.observer/filing/0001213900-24-072251.md","text":"https://secwatch.observer/filing/0001213900-24-072251.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072251/0001213900-24-072251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000121390024072251/ea021219701-8k_arcabio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T07:56:37.788293+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}